Teva Pharmaceutical Industries Ltd. — Earnings Release 2005

Feb 28, 2006

C001	��� ������ ��������� ��"�		2
Public	TEVA- PHARMACEUTICAL INDUSTRIES LTD.
	2529	Corporation no: 520013954
	Stock Exchange/Market: ���
	310
	379	P.O.B 3190 , Petach Tikva 49131 , ,
	Tel: 03-9267297 , 03-9267281 Fax: 03-9267429
	E.mail address: Liraz.Kalif@Teva.co.il	Date of transmission: 28/02/2006
		Time of broadcast: 07:04 07:02:30
		Reference: 2006-02-011272

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
TEVA REPORTS RECORD SALES AND NET INCOME FOR THE FOURTH QUARTER AND FULL YEAR 2005
Q4PR280206combined_isa.pdf

Please find attached a press release and its non-binding hebrew translation, provided for convenience purposes only
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 21/02/2006
- - -
Name of the Signatory : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il